Gilead has appointed Tahsin Gokcem Ozcagli as Medical Director. Prior to his new position, Ozcagli has worked as medical relations director at Gilead Turkey. In his new position, he will manage medical relations of the company’s operations in Eastern Europe covering 12 countries. Ozcagli completed his doctoral degree in pharmacology at Gazi University after receiving his bachelor’s degree from Ege University’s Faculty of Medicine. He began his professional career as a teaching assistant at the University of Alberta in Canada and joined the Novartis Family in 2005. Ozcagli continued his professional career as group medical director and Europe, Middle East and Africa (EMEA) area medical director at Abbott.
The CAD is big and its financing is bad!
To what extent does the misery index influence voters’ choices?
AI and beyond
Budget deficit risk of around 7% of GDP
Tourism revenues rise higher than the number of tourists
Need for anchor
Patents with technological advances in the automotive ecosystem
Let’s estimate FX rates…
Inflation soared while the policy rate was lowered
Famous banks’ election expectations
Energy and gold don’t explain the CAD
Levent Kafkasli becomes GM of GAP Insaat
Global tension: Is it decision time for Turkey?
When you don’t learn from a mistake from 30 years ago
UNDP sends containers to the quake-hit region
Annualized foreign trade deficit tripled in 1.5 years
KKM, liraization: Fiddlesticks!
Capacity usage down contrary to real sector confidence
Turkey at a Glance
DR. TAHSIN GOKCEM OZCAGLI BECOMES MEDICAL DIRECTOR OF GILEAD
July 12, 2021July 5, 2021
Leave a Reply